Rare Disease CME/CE Online Courses

myCMEYour search for high-quality, complimentary CME/CE stops right here. The courses below are presented by myCME, the continuing education engine in Haymarket Medical Network’s (HMN) expanding portfolio of clinical websites. Below you’ll find practice-relevant courses that carry valuable CME/CE credit. Simply click any link to get started earning credit on myCME.

Hereditary Pheochromocytoma and Paraganglioma: Strategies for Screening and Surveillance

Hereditary Pheochromocytoma and Paraganglioma

AMA PRA Category 1 Credit(s)TM
The goal of this activity is to provide clinicians with a brief review of hereditary paraganglioma-pheochromocytoma syndrome, SDHD-Associated tumor risks, and surveillance recommendations.
Expert Perspectives on Rare Disease: Promoting Recognition, Diagnosis and Treatment of Cold Agglutinin Disease

Promoting Recognition, Diagnosis and Treatment of CAD

AMA PRA Category 1 Credit(s)TM, ANCC Contact Hour(s)
In this activity, Catherine M. Broome, MD, and Alexander Röth, MD, provide an understanding of the pathogenesis of Cold Agglutinin Disease (CAD) caused by cold-reacting IgM autoantibodies and reveal common clinical features.
Tardive Dyskinesia and Affective Disorders: Nuances in the 21st Century?

Tardive Dyskinesia and Affective Disorders free CME | myCME

AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), AAPA Category I CME credit, CE for Pharmacists, CE for Psychologist
1 CME CE credit. Prevalence in mood disorders, differential diagnosis and evidence-based treatments for TD, including FDA approved treatments. Exp 6/7/22.
Critical Impact of Inflammation in Lysosomal Diseases: Unlocking Future Treatments and Improving Outcomes

Critical Impact of Inflammation in Lysosomal Diseases: Unlocking Future Treatments and Improving Outcomes | myCME

AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s)
The goal of this activity, which was held at WORLDSymposium 2021 will be to address the critical role of inflammation in lysosomal diseases, with a specific focus on inflammation in Gaucher disease, mucopolysaccharidosis type II (MPS II), and metachromatic leukodystrophy (MLD). Gaucher disease, MPS II, and MLD are three lysosomal diseases in which inflammation plays a significant role in disease progression and associated neurodegeneration.